Enjoy sizzling savings, fresh recipe inspiration and meaningful ways to give backLAKEWOOD, Colo., June 4, 2026 /PRNewswire/ -- Grilling season has arrived, and Natural...
Presale Tickets Tuesday 6/9 at 10AM LocalCORONA, Calif., June 4, 2026 /PRNewswire/ -- Rapidly rising Mexican electronic artist and producer duo RØZ have announced that...
From one million rooftops to a smarter, more resilient grid—how customer solar is powering the next era of clean energyOAKLAND, Calif., June 4, 2026...
Newest wave of consumer sentiment research reveals 73% of Americans are cutting nonessential spending while consumers grow more skeptical, cautious and deliberate about purchase...
TAIPEI, June 4, 2026 /PRNewswire/ -- At COMPUTEX 2026, the Taiwan Stock Exchange (TWSE) hosted two media briefings highlighting how Taiwan's capital markets are underpinning global...
LONDON, June 4, 2026 /PRNewswire/ -- New research from Pearson (FTSE: PSON.L), the world's lifelong learning company, suggests that UK teachers' confidence in using AI...
At the Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) which will this year take part in Istanbul, Türkiye from 12 to 15 June 2026, the Danish pharmaceutical company ALK will present data and key insights within anaphylaxis, food and respiratory allergy.
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).